Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma

International Journal of Colorectal Disease

Volumn 24, Issue 11, 2009, Pages 1287-1296

  Schmitz, Klaus Jürgen ^a   Müller, Carmen Ina ^a   Reis, Henning ^a   Alakus, Hakan ^b   Winde, Günther ^c   Baba, Hideo Andreas ^a   Wohlschlaeger, Jeremias ^a   Jasani, Bharat ^d   Fandrey, Joachim ^a   Schmid, Kurt Werner ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Klinikum Herford   (Germany)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Colorectal cancer; Hypoxia inducible factor; Metallothionein; Prognosis

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; METALLOTHIONEIN;

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

AMINO ACIDS, DICARBOXYLIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; METALLOTHIONEIN; PHENOTYPE; REACTIVE OXYGEN SPECIES; STAINING AND LABELING;

EID: 70350020416     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0753-8     Document Type: Article

References (48)

1. Abdel-Mageed AB, Agrawal KC (1998) Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res 58:2335-2338
2. Anne CH, Williams D, Anne TG (2000) Crypt-restricted metallothionein immunopositivity in murine colon: Validation of a model for studies of somatic stem cell mutation. J Pathol 191:306-312
3. Berchner-Pfannschmidt U, Yamac H, Trinidad B et al (2007) Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 282:1788-1796
4. Chubatsu LS, Meneghini R (1993) Metallothionein protects DNA from oxidative damage. Biochem J 291(Pt 1):193-198
5. Cleven AH, van Engeland M, Wouters BG et al (2007) Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cell Oncol 29:229-240
6. Coyle P, Philcox JC, Carey LC et al (2002) Metallothionein: The multipurpose protein. Cell Mol Life Sci 59:627-647
7. Dalton T, Paria BC, Fernando LP et al (1997) Activation of the chicken metallothionein promoter by metals and oxidative stress in cultured cells and transgenic mice. Comp Biochem Physiol B Biochem Mol Biol 116:75-86
8. Donnelly ET, Bardwell H, Thomas GA et al (2005) Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. Br J Cancer 92:2160-2165
9. Duncan EL, Reddel RR (1999) Downregulation of metallothionein-IIA expression occurs at immortalization. Oncogene 18:897-903
10. Dziegiel P, Forgacz J, Suder E et al (2003) Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine. Histol Histopathol 18:401-407
11. Ema M, Taya S, Yokotani N et al (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94:4273-4278
12. Gu YZ, Moran SM, Hogenesch JB et al (1998) Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 7:205-213
13. Hamilton SR, Aaltonen LA (eds) (2000) Pathology and genetics of tumours of the digestive system (World Health Organization classification of tumours). IARC Press, Lyon
14. Harris AL (2002) Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2:38-47
15. Hopfl G, Ogunshola O, Gassmann M (2004) HIFs and tumors - causes and consequences. Am J Physiol Regul Integr Comp Physiol 286:R608-R623
16. Ioachim EE, Goussia AC, Agnantis NJ et al (1999) Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J Clin Pathol 52:876-879
17. Ivan M, Kondo K, Yang H et al (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468
18. Jaakkola P, Mole DR, Tian YM et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472
19. Janssen AM, van Duijn W, Oostendorp-Van De Ruit MM et al (2000) Metallothionein in human gastrointestinal cancer. J Pathol 192:293-300
20. Jasani B, Schmid KW (1997) Significance of metallothionein overexpression in human tumours. Histopathology 31:211-214
21. Jiang BH, Agani F, Passaniti A et al (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression. Cancer Res 57:5328-5335
22. Kagi JH (1991) Overview of metallothionein. Methods Enzymol 205:613-626
23. Kamura T, Sato S, Iwai K et al (2000) Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA 97:10430-10435
24. Koukourakis MI, Giatromanolaki A, Polychronidis A et al (2006) Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci 97:582-588
25. Kuwai T, Kitadai Y, Tanaka S et al (2003) Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105:176-181
26. Laity JH, Andrews GK (2007) Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch Biochem Biophys 463:201-210
27. Lazo JS, Pitt BR (1995) Metallothioneins and cell death by anticancer drugs. Annu Rev Pharmacol Toxicol 35:635-653
28. Liu B, Chen Y, St Clair DK (2008) ROS and p53: A versatile partnership. Free Radic Biol Med 44:1529-1535
29. Masson N, Ratcliffe PJ (2003) HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci 116:3041-3049
30. Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275
31. Meplan C, Richard MJ, Hainaut P (2000) Metalloregulation of the tumor suppressor protein p53: Zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19:5227-5236
32. Murphy BJ, Laderoute KR, Chin RJ et al (1994) Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res 54:5808-5810
33. Murphy BJ, Andrews GK, Bittel D et al (1999) Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res 59:1315-1322
34. Murphy BJ, Kimura T, Sato BG et al (2008) Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1alpha. Mol Cancer Res 6:483-490
35. Ofner D, Maier H, Riedmann B et al (1994) Immunohistochemical metallothionein expression in colorectal adenocarcinoma: Correlation with tumour stage and patient survival. Virchows Arch 425:491-497
36. Palmiter RD (1998) The elusive function of metallothioneins. Proc Natl Acad Sci USA 95:8428-8430
37. Sato M, Bremner I (1993) Oxygen free radicals and metallothionein. Free Radic Biol Med 14:325-337
38. Schmitz KJ, Wohlschlaeger J, Alakus H et al (2007) Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations. Virchows Arch 450:151-159
39. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732
40. Skroch P, Buchman C, Karin M (1993) Regulation of human and yeast metallothionein gene transcription by heavy metal ions. Prog Clin Biol Res 380:113-128
41. Stewart BW, Kleihus P (2003) World cancer report. IARC Press, Lyon
42. Sun X, Kanwar JR, Leung E et al (2001) Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy. Gene Ther 8:638-645
43. Talks KL, Turley H, Gatter KC et al (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157:411-421
44. Theocharis SE, Margeli AP, Klijanienko JT et al (2004) Metallothionein expression in human neoplasia. Histopathology 45:103-118
45. Theodoropoulos GE, Lazaris AC, Theodoropoulos VE et al (2006) Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis 21:248-257
46. Wang GL, Jiang BH, Rue EA et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514
47. Yoshimura H, Dhar DK, Kohno H et al (2004) Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: Correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 10:8554-8560
48. Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830-5835